北京美科美生物公司代理nhdiag

Medical Tests
Bioenvironmental and Biothreat Detection
Food Testing
Ordering


成立于1981年。该公司开发了快速微生物检测技术，包括第一个基于金的免疫分析和一个基于发光的ATP检测系统，可以区分微生物和体细胞反应。

创新和关键的联盟是新视野持续成功的标志。该公司已扩大其技术基础，包括自身免疫和传染病的预防和治疗。这些包括使用人源化抗细胞因子单克隆抗体和用噬菌体相关的裂解酶治疗细菌感染。新的测试格式包括手持式超灵敏荧光系统和使用即时诊断设备测试口腔液的方法。

该公司专门开发独特的技术，旨在快速检测、处理或净化特定微生物的存在。目前，美国国家卫生和健康研究所生产的检测试剂盒旨在识别与动物和人类传染病有关的微生物(a);(b)食品污染;(c)生物战争;(d)环境危害。
was founded in 1981. It has developed rapid microbial detection technologies, including the first gold-based immunoassay and a luminescent-based ATP detection System that discriminates microbial from somatic cell responses.

Innovation and critical alliances have hallmarked the continuing success of New Horizons. The company has expanded its technology base to include the prevention and treatment of autoimmune and infectious diseases. These include the use of humanized anti-cytokine monoclonal antibodies and the treatment of bacterial infection with Phage associated lytic enzymes. New test formats include a hand held ultra-sensitive fluorescence system and methods for testing oral fluids with point-of-care diagnostic devices.

The company specializes in the development of unique technologies that have been designed to rapidly detect, treat, or decontaminate the presence of selected microorganisms. Currently, NHD manufactures test kits designed to identify microorganisms associated with (a) infectious diseases in animals and humans; (b) food contamination; (c) biological warfare; and (d) environmental hazards.